Please login to the form below

Not currently logged in
Email:
Password:

Cello Health acquires Advantage Healthcare to strengthen its US presence

Biopharmaceutical insight group boosts Cello’s reach

Cello HealthHealth communications and consultancy group Cello Health has bolstered its US reach by acquiring critical analysis and biopharmaceutical insight firm Advantage Healthcare.

The deal will add to Cello Health’s growing US presence and Advantage Healthcare will provide support to global client companies, with senior team members bringing marketing and market research expertise.

Stephen Highley, chairman of Cello Health, said: “We are very pleased to welcome Advantage Healthcare to the group.

“They have achieved an excellent reputation for the services they provide, which fits perfectly with our strategy of addressing our clients’ difficult challenges with high-end advisory services.”

New York and New Jersey, US-based Advantage Healthcare was founded in 1994, focussing on commercial assessments, analog intelligence and a specific rapid response service that provides for turnarounds of half or less than typical timelines.

Debbie Glick, president and founder of Advantage Healthcare, said: “Joining Cello Health will provide a win-win combination for our global healthcare clients, offering a broad base of strategic expertise and service in pipeline and marketed products across nearly 100 disease categories.”

Article by
Gemma Jones

20th July 2017

From: Marketing

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Frontera Group

Welcome to Frontera Group where our agencies immerse you into the world of the patient....

Latest intelligence

AstraZeneca’s oncology renaissance
Susan Galbraith played a key role in restoring AstraZeneca’s place in cancer drug development – she talks about the future of oncology and why there’s more to be done to...
Navigating the antibiotic resistance crisis
Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial resistance crisis, and learn how a simple tool could support physicians...
Combined immunotherapies – potential and pitfalls
‘Combining therapeutic compounds is the first logical step towards better results, namely higher rates of patients responding to treatment, with deeper and more sustained responses’...

Infographics